# Use of Phenylephrine for Assessment of Mitral Regurgitation Severity

> **NCT04500899** · PHASE1,PHASE2 · RECRUITING · sponsor: **Montefiore Medical Center** · enrollment: 35 (estimated)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DRUG:** Mydfrin

## Key facts

- **NCT ID:** NCT04500899
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500899, "Use of Phenylephrine for Assessment of Mitral Regurgitation Severity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04500899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*